In the draft guidance, the agency discusses how sponsors can leverage MRD and complete response rates as near-term efficacy measures and speed new therapies to market.

As Hytale develops further in Early Access, developer Hypixel Studios has opened up about the future of world generation with ...

In today's healthcare environment, securing regulatory approval is only the beginning. The real challenge lies in ensuring ...

METR’s benchmark has become a bellwether of AI capability growth, but its design isn’t up to the task, argues Nathan Witkin ...

The head of the Department of Health and Human Services has spent decades promoting vaccine skepticism and has now revamped the US childhood immunization schedule to have one-third fewer recommended ...

This is interesting because DCC came out in the waning days of D&D’s 4e, which was disliked even more by players, but a ...

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss ...

Objectives This scoping review addresses the underexplored issue of abuse of people with mental illnesses by healthcare ...

With Persona 3 Reload and Persona 5 Royal released, we rank the 12 best Persona games to see how the classics stack up ...

Have you been shopping for wellness gear and realized you might be comparing apples to oranges? Red light therapy and ...

Coupling biomarker-guided screening with a targeted treatment bundle reduced newborn mortality, hospital stays, and other complications over standard care, according to a recent study.

Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...